MIR3681

Across TCGA pan-cancer cohorts, MIR3681 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated MIR3681 data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher MIR3681 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR3681 expression acts as an unfavorable survival marker, although some lineages such as OV and ESCA show a favorable association.

KIRP, BLCA, and ACC are the cancer types where MIR3681 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	All	0.151	0.709	<.001	66	view →
BLCA	OS	Tertile	III,IV	0.133	0.684	<.001	54	view →
ACC	DFS	Tertile	All	0.048	0.667	<.001	54	view →
BRCA	OS	Tertile	All	0.103	0.578	.025	36	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
SKCM	DFS	Tertile	All	0.192	0.757	.022	18	view →
STAD	OS	Tertile	II,III,IV	0.450	0.725	.014	18	view →
OV	OS	Tertile	II,III,IV	0.573	0.309	.020	18	view →
KIRC	DFS	Tertile	IV	0.167	0.605	<.001	18	view →
SARC	OS	Tertile	All	0.299	0.775	<.001	18	view →
LGG	DFS	Tertile	All	0.258	0.733	<.001	15	view →
ESCA	DFS	Tertile	III,IV	1.000	0.280	.042	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

MIR3681–KIRP (OS)

Open the KIRP breakdown →